• Molecular NameUrofollitropin
  • SynonymFollicle-stimulating hormone beta subunit; Follitropin beta chain precursor; FSH-B; FSH-beta
  • Weight980.179
  • Drugbank_IDDB00094
  • ACS_NO146479-72-3
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-2.26
  • pkaN/A
  • LogD (pH=7, predicted)-2.37
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.95
  • LogSw (predicted, AB/LogsW2.0)1.94
  • Sw (mg/ml) (predicted, ACD/Labs)9.92
  • No.of HBond Donors15
  • No.of HBond Acceptors23
  • No.of Rotatable Bonds15
  • TPSA427.27
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA purified form of follicle-stimulating hormone (FSH). FSH is important in the development of follicles (eggs) produced by the ovaries. Given by subcutaneous injection, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. It is also used with in vitro fertilization methods.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A